Idea: Long BAM (Brookfield Asset Management)
Entry: $52.00
**Stop Loss:** $48.00
Take Profit: $63.00
**Risk/Reward:** 1:2.75 (Risk $4 / Reward $11)
Timeframe: Swing / Position Trading (Weeks to Months)

The Setup

Brookfield just delivered record Q2 results that the market only partially rewarded. The stock traded $50–$53.88 on August 5, closing at $51.94, up 2.47%. The pullback from the high is healthy consolidation, creating an attractive entry near $52.

Fee-related earnings hit $808M, +20% YoY, with a record $77B raised in the quarter. AUM reached $1.3T, up from $1.2T in Q1. YTD fundraising stands at $98B, with $163B over the trailing 12 months. The board declared a quarterly dividend of $0.5025/share, payable September 29.

The Fundamentals

Revenue of $1.75B beat the $1.47B consensus. FRE margin was 57% for the quarter, 58% over twelve months. Adjusted earnings were $707M or $0.44/share. The $40B Just Group mandate increased insurance capital under management by over one-third.

According to GuruFocus, BAM is 15.5% undervalued on GF Value. The stock trades 24% above its 52-week low of $42.20 but still 18% below its high of $64.10.

Analyst Backing

The 18-analyst consensus is Buy with a $58.01 average target, implying 11.7% upside. The high target is $69, low $49. Goldman Sachs maintains Buy with $54, BMO reiterated Outperform, noting BAM is well-positioned for double-digit growth in fee-generating capital.

Technical Setup

BAM is trading 2.5% above its 20-day SMA ($48.02) and 7.1% above its 50-day SMA ($45.95), confirming the intermediate uptrend. RSI at 59 is bullish with room to run. Key support sits at $50 (intraday low and psychological level) followed by $49. Resistance lies at $53.88 then $58.01.

The software gives BAM Score Pro 5.0 with Daily and 4H in Buy, while 1H shows Strong Sell — signaling a healthy pullback before the next leg up.

The Trade

Entry at $52 offers margin above the $50 intraday low and 20-day SMA. Stop at $48 sits just below the SMA for structural protection. Target at $63 aligns with high-end analyst targets while staying below the $64.10 52-week high.

The 1:2.75 R/R ratio provides favorable asymmetry — risking $4 to gain $11.

The Catalyst

Q2 earnings beat on August 5 was the primary catalyst. The pullback is classic post-earnings digestion. The story remains intact: record fundraising, $1.3T AUM, insurance capital up one-third, 3.8% dividend yield, and 15.5% undervaluation.

Key Risks

BAM's beta of ~1.3 makes it sensitive to market moves. Any fundraising slowdown or currency headwinds could pressure the stock. A break below $48 would invalidate the thesis.

Conclusion

BAM offers a high-probability setup on three pillars. Fundamentally, record Q2 results, $1.3T AUM, 15.5% undervaluation, and a 3.8% dividend. Technically, bullish daily structure with RSI at 59 and price above key moving averages. Institutionally, 18 analysts with a Buy consensus and average target of $58.01.

Entry $52, Stop $48, Target $63 — a clean, risk-defined setup with favorable asymmetry. Buying this pullback after record earnings, with strong institutional backing and an attractive valuation, should be well-rewarded.

⚠️ Disclaimer: This is a personal trading idea, not financial advice. Trading involves substantial risk of loss. Always conduct your own research and risk assessment.